Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging indications for permanent pacing.

D L Wolbrette1, G V Naccarelli

  • 1Section of Cardiology, PennState University Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA. dwolbret@psu.edu

Current Cardiology Reports
|August 23, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.

Journal of internal medicine·2007
Same author

Report of the NASPE policy conference on arrhythmias and the athlete.

Journal of cardiovascular electrophysiology·2001
Same author

Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation.

Pacing and clinical electrophysiology : PACE·2001
Same author

Reprocessing of electrophysiology catheters: clinical studies, regulations, and recommendations. A report of the NASPE Task Force on Reprocessing of Electrophysiological Catheters. North American Society of Pacing and Electrophysiology.

Pacing and clinical electrophysiology : PACE·2001
Same author

Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2001
Same author

The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities.

The American journal of medicine·2001
Same journal

Diagnostic Tests for Stage B Heart Failure.

Current cardiology reports·2026
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
Same journal

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
See all related articles

Pacemaker therapy is being explored for conditions like vasovagal syncope and heart failure. Pacing shows promise for atrial fibrillation and specific heart conditions, offering alternatives to traditional treatments.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Technology

Background:

  • Pacemaker technology is evolving beyond traditional uses.
  • Investigating new applications for pacing in complex cardiovascular conditions.
  • Exploring pacing as an alternative for patients unresponsive to medical treatments.

Purpose of the Study:

  • To review current and emerging indications for cardiac pacing.
  • To evaluate the efficacy of pacing in vasovagal syncope, cardiomyopathies, and atrial fibrillation.
  • To identify areas for technological advancement in pacing lead systems.

Main Methods:

  • Review of current clinical data and ongoing research in cardiac pacing.
  • Analysis of patient outcomes for various pacing strategies.

Related Experiment Videos

  • Assessment of technological limitations and future directions for pacing leads.

    • Main Results:

    • Pacing for vasovagal syncope may benefit highly symptomatic patients with a cardioinhibitory component.
    • Dual-chamber pacing is not equivalent to septal myectomy for hypertrophic obstructive cardiomyopathy but may suit specific patient groups.
    • Biventricular/left ventricular pacing shows promise for heart failure, potentially combined with implantable cardioverter-defibrillator therapy.
    • Dual-site atrial pacing may help prevent atrial fibrillation recurrence.

    Conclusions:

    • Cardiac pacing offers expanding therapeutic options for various cardiovascular diseases.
    • Further lead technology development is needed for optimal coronary vein placement.
    • Pacing can serve as a valuable adjunct to existing therapies for atrial fibrillation and heart failure.